 "Biocon sets price band for clinical services arm Syngene's IPO")
Drugmaker Biocon Ltd has set the price band for an initial public offering (IPO) of its clinical research services arm, Syngene International Ltd, at Rs 240 to Rs 250 a share, it said on Thursday.
Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.
Biocon said in April that it planned to sell 22 million shares and provide an overallotment option.
($1 = 62.9100 rupees)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app